...
首页> 外文期刊>ACS Omega >Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure
【24h】

Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure

机译:四氢异喹啉磺酸盐作为有效的微管破坏者:二氯苄基衍生物的合成,抗增殖和抗微管蛋白活性,以及​​微管蛋白共晶体结构

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Tetrahydroisoquinoline (THIQ) 6-O-sulfamate-based anticancer agents, inspired by the endogenous steroid 2-methoxyestradiol and its sulfamate derivatives, are further explored for antiproliferative and microtubule disruptor activity. Based on recently designed C3-methyl C7-methoxy-substituted THIQ derivatives, compounds with mono- and dichloro-substitutions on the pendant N-benzyl ring were synthesized and evaluated. Although improved antiproliferative activity was observed, for example, 4a versus 4b and 4b versus 8c, it was relatively modest. Compound 8c, a 2′,5′-dichlorobenzyl derivative was, however, identified as a promising antiproliferative agent with in vitro activities exceeding that of the parent steroid (e.g., GI50 90 nM in DU-145 cells) and was highly potent against a range of tumor cell lines (e.g., GI50 26 nM for OVCAR-3). 8c inhibited the polymerization of tubulin in vitro with an IC50 only twofold less potent than combretastatin A-4 and inhibited colchicine binding to tubulin. Tubulin polymerization assays showed the parent THIQ 4a to be only a very weak inhibitor, but a striking potency difference was seen between compounds with C2′ methoxy and chloro substituents, whereas this was much smaller when these substituents were positioned at C5′. To confirm the target in atomic detail and because 8c is a racemic mixture, an achiral parent THIQ 6-O-sulfamate derivative 10 was successfully cocrystallized with the αβ-tubulin heterodimer. The derivative 10 binds at the colchicine site on tubulin, the first example of this compound class investigated in such detail, with its sulfamate group interacting with residues beyond the reach of colchicine itself, similar to a recently reported quinazolinone sulfamate derivative, 6a. The structure also suggests that for racemic C3-methyl-substituted THIQ derivatives, such as 8c, the (S)-enantiomer is likely to be preferentially accommodated within the colchicine site for steric reasons. The results further confirm the potential of nonsteroidal THIQ sulfamate derivatives for oncology and suggest that the mechanism of microtubule destabilization for the THIQ compound class is to prevent the curved-to-straight conformational transition of tubulin required for polymerization.
机译:受内源性类固醇2-甲氧基雌二醇及其氨基磺酸衍生物的启发,进一步研究了基于四氢异喹啉(THIQ)6-O-氨基磺酸盐的抗癌药的抗增殖和微管破坏活性。基于最近设计的C3-甲基C7-甲氧基取代的THIQ衍生物,合成并评估了在N-苄基侧链上具有单和二氯取代基的化合物。尽管观察到抗增殖活性有所提高,例如4a对4b和4b对8c,但相对适度。然而,化合物8c(一种2',5'-二氯苄基衍生物)被认为是一种有前途的抗增殖剂,其体外活性超过了其母体类固醇的活性(例如DU-145细胞中的GI50 90 nM),并且对肿瘤细胞系的范围(例如OVCAR-3的GI50 26 nM)。 8c在体外抑制微管蛋白的聚合,其IC 50的效力仅比康培他汀A-4低两倍,并且抑制秋水仙碱与微管蛋白的结合。微管蛋白聚合测定显示母体THIQ 4a只是非常弱的抑制剂,但是在具有C2'甲氧基和氯取代基的化合物之间发现了惊人的效能差异,而当这些取代基位于C5'处时,该效能差异要小得多。为了在原子细节上确认目标,并且由于8c是外消旋混合物,非手性母体THIQ 6-O-氨基磺酸酯衍生物10与αβ-微管蛋白异二聚体成功共结晶。衍生物10结合在微管蛋白的秋水仙碱位点上,这是这类化合物的第一个详细研究的实例,其氨基磺酸盐基团与秋水仙碱本身无法达到的残基相互作用,类似于最近报道的喹唑啉酮氨基磺酸盐衍生物6a。该结构还表明,对于外消旋的C3-甲基取代的THIQ衍生物,例如8c,由于空间原因,(S)-对映异构体可能优先被置于秋水仙碱位点内。结果进一步证实了非甾体类THIQ氨基磺酸盐衍生物在肿瘤学中的潜力,并表明THIQ化合物类别的微管去稳定机理是为了防止聚合所需的微管蛋白从弯曲到笔直的构象转变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号